Scinai Immunotherapeutics Total Assets

Scinai Immunotherapeutics (SCNI) currently reports a total assets of $17M as of June 2026. That compares with $12M in the prior-year period — up 45.1% year over year. Use the charts on this page to explore Scinai Immunotherapeutics's total assets history and peer comparisons.

Scinai Immunotherapeutics's total assets increased from $12M to $17M — a 45.1% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Scinai Immunotherapeutics reported $17M in total assets as of June 2026. That compares with $12M in the prior-year period — up 45.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total assets of $17M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Scinai Immunotherapeutics, and consider following SCNI for alerts when major investors trade the stock.

Scinai Immunotherapeutics is classified in the Healthcare sector. On total assets, it currently shows $17M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SCNI with unrelated industries.